Atlas Trials

Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris

Clinical trial NCT00835198 · COMPLETED

Trial details

NCT number
NCT00835198
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2008-12-01
Primary completion
2009-08-01
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.